Back
Virtus Duff & Phelps Clean Energy ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
28
VCLN
Virtus Duff & Phelps Clean Energy ETF
Last Price:
17.87
Seasonality Move:
-8.67%
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
138.01
Seasonality Move:
14.88%
Sell
28
Virtus Duff & Phelps Clean Energy ETF (VCLN)
is a Sell
Is Virtus Duff & Phelps Clean Energy ETF a Buy, Sell or Hold?
- The current Virtus Duff & Phelps Clean Energy ETF [VCLN] share price is $18.20. The Score for VCLN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- VCLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCLN Stock Price Chart
What is Virtus Duff & Phelps Clean Energy ETF's stock price today?
-
The Virtus Duff & Phelps Clean Energy ETF share price today is $18.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VCLN is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $137.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
VCLN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 54.61 | Buy |
Chaikin Money Flow: | -124 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.51 - 18.29) | Buy |
Bollinger Bands (100): | (17.91 - 19.13) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 69.97 | Buy |
Chaikin Money Flow: | 2429824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.69) | Buy |
Bollinger Bands (100): | (119.21 - 142.01) | Buy |
VCLN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.86 | Buy |
20-day SMA: | 17.82 | Buy |
50-day SMA: | 18.52 | Sell |
200-day SMA: | 18.13 | Buy |
8-day EMA: | 17.95 | Buy |
20-day EMA: | 17.93 | Buy |
50-day EMA: | 18.23 | Sell |
200-day EMA: | 18.34 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.25 | Buy |
20-day SMA: | 117.78 | Buy |
50-day SMA: | 122.17 | Buy |
200-day SMA: | 130.04 | Buy |
8-day EMA: | 121.1 | Buy |
20-day EMA: | 119.12 | Buy |
50-day EMA: | 122.54 | Buy |
200-day EMA: | 126.1 | Buy |
Virtus Duff & Phelps Clean Energy ETF Earnings Growth & VCLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Virtus Duff & Phelps Clean Energy ETF Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |